The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
ObsEva SA(NASDAQ:OBSV) 
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. The company is developing Linzagolix, an oral gonadotropin-releasing hormone receptor antagonist for the treatment of pain associ...
Website: http://www.obseva.com
Founded: 2012
Full Time Employees: 42 (May 2021)
Sector: Healthcare
Industry: Biotechnology
ObsEva SA Days Receivable Outstanding ttm (DSO)
ObsEva SA Op Cashflow Per Share ttm
ObsEva SA Free Cashflow Per Share ttm
ObsEva SA Cash Per Share ttm
ObsEva SA P/S ratio ttm
ObsEva SA (GAAP) P/E ratio ttm
ObsEva SA P/B ratio ttm
No extra charts and metrics for this ticker.